내용 바로 가기

종양학과

빈혈 관리

적혈구생성자극제(Erythropoiesis-Stimulating Agents)

Management of anaemia and iron deficiency in patients with cancer: ESMO clinical practice guidelines. (새로운 창 열기)

Aapro M, Beguin Y, Bokemeyer C, Dicato M, Gascón P, Glaspy J, Hofmann A, Link H, Littlewood T, Ludwig H, Österborg A, Pronzato P, Santini V, Schrijvers D, Stauder R, Jordan K, Herrstedt J; ESMO Guidelines Committee

Source‎: Ann Oncol 2018;29(Supplement_4):iv96-110.

Indexed‎: PubMed 29471514

DOI‎: 10.1093/annonc/mdx758

https://www.ncbi.nlm.nih.gov/pubmed/29471514 (새로운 창 열기)

Recombinant human erythropoietin is associated with increased overall survival in patients with multiple myeloma. (새로운 창 열기)

Baz R, Walker E, Choueiri TK, Abou Jawde R, Brand C, McGowan B, Yiannaki E, Andresen S, Hussein MA.

Source‎: Acta Haematol 2007;117(3):162-7.

Indexed‎: PubMed 17148935

DOI‎: 10.1159/000097464

https://www.ncbi.nlm.nih.gov/pubmed/17148935 (새로운 창 열기)

Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation: a prospective multicenter randomized trial. (새로운 창 열기)

Beguin Y, Maertens J, De Prijck B, Schots R, Seidel L, Bonnet C, Hafraoui K, Willems E, Vanstraelen G, Servais S, Jaspers A, Fillet G, Baron F.

Source‎: Am J Hematol 2013;88(12):990-6.

Indexed‎: PubMed 23873823

DOI‎: 10.1002/ajh.23552

https://www.ncbi.nlm.nih.gov/pubmed/23873823 (새로운 창 열기)

Randomized phase III trial of sequential adjuvant chemoradiotherapy with or without erythropoietin alfa in patients with high-risk cervical cancer: results of the NOGGO-AGO intergroup study. (새로운 창 열기)

Blohmer JU, Paepke S, Sehouli J, Boehmer D, Kolben M, Würschmidt F, Petry KU, Kimmig R, Elling D, Thomssen C, von Minckwitz G, Möbus V, Hinke A, Kümmel S, Budach V, Lichtenegger W, Schmid P.

Source‎: J Clin Oncol 2011;29(28):3791-7.

Indexed‎: PubMed 21860000

DOI‎: 10.1200/JCO.2010.30.4899

https://www.ncbi.nlm.nih.gov/pubmed/21860000 (새로운 창 열기)

Epoetin alpha decreases the number of erythrocyte transfusions in patients with acute lymphoblastic leukemia, lymphoblastic lymphoma, and Burkitt leukemia/lymphoma: results of a randomized clinical trial. (새로운 창 열기)

Cabanillas ME, Kantarjian H, Thomas DA, Mattiuzzi GN, Rytting ME, Bruera E, Xiao L, Bekele BN, Foudray MC, Cortes JE.

Source‎: Cancer 2012;118(3):848-55.

Indexed‎: PubMed 21751205

DOI‎: 10.1002/cncr.26341

https://www.ncbi.nlm.nih.gov/pubmed/21751205 (새로운 창 열기)

Management of anemia in cancer patients. (새로운 창 열기)

Calabrich A, Katz A.

Source‎: Future Oncol 2011;7(4):507-17.

Indexed‎: PubMed 21463140

DOI‎: 10.2217/fon.11.24

https://www.ncbi.nlm.nih.gov/pubmed/21463140 (새로운 창 열기)

The short-term use of erythropoetin-stimulating agents: impact on the biochemical recurrence of prostate cancer. (새로운 창 열기)

Djavan B, Laze J, Eckersberger E, Finkelstein J, Agalliu I, Lepor H.

Source‎: BJU Int 2011;108(10):1582-7.

Indexed‎: PubMed 21443653

DOI‎: 10.1111/j.1464-410X.2011.10173.x

https://www.ncbi.nlm.nih.gov/pubmed/21443653 (새로운 창 열기)

Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial. (새로운 창 열기)

Engert A, Josting A, Haverkamp H, Villalobos M, Lohri A, Sökler M, Zijlstra J, Sturm I, Topp MS, Rank A, Zenz T, Vogelhuber M, Nogova L, Borchmann P, Fuchs M, Flechtner HH, Diehl V.

Source‎: J Clin Oncol 2010;28(13):2239-45.

Indexed‎: PubMed 20368566

DOI‎: 10.1200/JCO.2009.25.1835

https://www.ncbi.nlm.nih.gov/pubmed/20368566 (새로운 창 열기)

Randomised, phase III trial of epoetin-β to treat chemotherapy-induced anaemia according to the EU regulation. (새로운 창 열기)

Fujisaka Y, Sugiyama T, Saito H, Nagase S, Kudoh S, Endo M, Sakai H, Ohashi Y, Saijo N.

Source‎: Br J Cancer 2011;105(9):1267-72.

Indexed‎: PubMed 21959870

DOI‎: 10.1038/bjc.2011.395

https://www.ncbi.nlm.nih.gov/pubmed/21959870 (새로운 창 열기)

Erythropoiesis-stimulating agents significantly delay the onset of a regular transfusion need in nontransfused patients with lower-risk myelodysplastic syndrome. (새로운 창 열기)

Garelius HK, Johnston WT, Smith AG, Park S, de Swart L, Fenaux P, Symeonidis A, Sanz G, Čermák J, Stauder R, Malcovati L, Mittelman M, van de Loosdrecht AA, van Marrewijk CJ, Bowen D, Crouch S, de Witte TJ, Hellström-Lindberg E.

Source‎: J Intern Med 2017;281(3):284-99.

Indexed‎: PubMed 27926979

DOI‎: 10.1111/joim.12579

https://www.ncbi.nlm.nih.gov/pubmed/27926979 (새로운 창 열기)

How I treat cancer-associated anemia. (새로운 창 열기)

Gilreath JA, Rodgers GM

Source‎: Blood 2020;136(7):801-13.

Indexed‎: PubMed 32556170

DOI‎: 10.1182/blood.2019004017

https://www.ncbi.nlm.nih.gov/pubmed/32556170 (새로운 창 열기)

Biosimilar erythropoiesis-stimulating agents are an effective and safe option for the management of myelofibrosis-related anemia. (새로운 창 열기)

Inzoli E, Crisà E, Pugliese N, Civettini I, Lanzarone G, Castelli A, Martinelli V, Montelisciani L, Antolini L, Gambacorti-Passerini C, Elli EM

Source‎: Eur J Haematol. 2023 110(4):354-61.

Indexed‎: PubMed 36480004

DOI‎: 10.1111/ejh.13910

https://pubmed.ncbi.nlm.nih.gov/36480004/ (새로운 창 열기)

A randomized controlled trial comparing darbepoetin alfa doses in red blood cell transfusion-dependent patients with low- or intermediate-1 risk myelodysplastic syndromes. (새로운 창 열기)

Jang JH, Harada H, Shibayama H, Shimazaki R, Kim HJ, Sawada K, Mitani K.

Source‎: Int J Hematol 2015;102(4):401-12.

Indexed‎: PubMed 26323997

DOI‎: 10.1007/s12185-015-1862-5

https://www.ncbi.nlm.nih.gov/pubmed/26323997 (새로운 창 열기)

Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients. (새로운 창 열기)

Michallet M, Goldet K, Sobh M, Morisset S, Chelghoum Y, Thomas X, Barraco F, Ducastelle S, Labussière H, Renzullo C, Paillet C, Pivot C, Straaten PB, Denis A, Termoz A, Detrait M, Nicolini FE, Jaisson-Hot I.

Source‎: Cancer 2013;119(1):107-14.

Indexed‎: PubMed 22744794

DOI‎: 10.1002/cncr.27686

https://www.ncbi.nlm.nih.gov/pubmed/22744794 (새로운 창 열기)

Adding epoetin alfa to intense dose-dense adjuvant chemotherapy for breast cancer: randomized clinical trial. (새로운 창 열기)

Moebus V, Jackisch C, Schneeweiss A, Huober J, Lueck HJ, du Bois A, Thomssen C, Kurbacher C, Kuhn W, Nitz U, Runnebaum IB, Hinke A, Kreienberg R, Untch M; on behalf of the AGO Breast Study Group.

Source‎: J Natl Cancer Inst 2013;105(14):1018-26.

Indexed‎: PubMed 23860204

DOI‎: 10.1093/jnci/djt145

https://www.ncbi.nlm.nih.gov/pubmed/23860204 (새로운 창 열기)

Meta-analysis of epoetin beta and darbepoetin alfa treatment for chemotherapy-induced anemia and mortality: Individual patient data from Japanese randomized, placebo-controlled trials. (새로운 창 열기)

Ohashi Y, Uemura Y, Fujisaka Y, Sugiyama T, Ohmatsu H, Katsumata N, Okamoto R, Saijo N, Hotta T.

Source‎: Cancer Sci 2013;104(4):481-5.

Indexed‎: PubMed 23331490

DOI‎: 10.1111/cas.12105

https://www.ncbi.nlm.nih.gov/pubmed/23331490 (새로운 창 열기)

Outcomes of erythropoiesis-stimulating agents in cancer patients with chemotherapy-induced anemia. (새로운 창 열기)

Pashos CL, Larholt K, Fraser KA, McKenzie RS, Senbetta M, Piech CT.

Source‎: Support Care Cancer 2012;20(1):159-65.

Indexed‎: PubMed 21359879

DOI‎: 10.1007/s00520-010-1083-7

https://www.ncbi.nlm.nih.gov/pubmed/21359879 (새로운 창 열기)

High-dose chemotherapy without transfusion for Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in two Jehovah's Witnesses patients: a feasible option in the age of hematopoietic growth factors. (새로운 창 열기)

Perol L, Grignano E, Contejean A, Gastaud L, Legoff M, Franchi P, Deau-Fischer B, Willems L, Bouscary D, Tamburini J

Source‎: Leuk Lymphoma. 2019;60(9):2324-7.

Indexed‎: PubMed 30773115

DOI‎: 10.1080/10428194.2019.1577414

https://www.ncbi.nlm.nih.gov/pubmed/30773115 (새로운 창 열기)

Epoetin alfa improves anemia and anemia-related, patient-reported outcomes in patients with breast cancer receiving myelotoxic chemotherapy: results of a European, multicenter, randomized, controlled trial. (새로운 창 열기)

Pronzato P, Cortesi E, van der Rijt CC, Bols A, Moreno-Nogueira JA, de Oliveira CF, Barrett-Lee P, Ostler PJ, Rosso R; for the EPO-INT-47 Study Group.

Source‎: Oncologist 2010;15(9):935-43.

Indexed‎: PubMed 20798194

DOI‎: 10.1634/theoncologist.2009-0279

https://www.ncbi.nlm.nih.gov/pubmed/20798194 (새로운 창 열기)

Benefits and risks of using erythropoiesis-stimulating agents (ESAs) in lung cancer patients: study-level and patient-level meta-analyses. (새로운 창 열기)

Vansteenkiste J, Glaspy J, Henry D, Ludwig H, Pirker R, Tomita D, Collins H, Crawford J.

Source‎: Lung Cancer 2012;76(3):478-85.

Indexed‎: PubMed 22277104

DOI‎: 10.1016/j.lungcan.2011.12.015

https://www.ncbi.nlm.nih.gov/pubmed/22277104 (새로운 창 열기)

Response to erythropoietic-stimulating agents in patients with chronic myelomonocytic leukemia. (새로운 창 열기)

Xicoy B, Germing U, Jimenez MJ, Garcia O, Garcia R, Schemenau J, Pedro C, Luño E, Bernal T, González B, Strupp C, Ardanaz M, Kuendgen A, Cedena MT, Neukirchen J, Calabuig M, Brunet S, Medina A, Amigo ML, Ramos F, Callejas M, Díez-Campelo M, Bailén A, Collado R, Vicente A, Arnan M, Valcarcel D, Arilla MJ, Zamora L, Benlloch L, Sanz G.

Source‎: Eur J Haematol 2016;97(1):33-8.

Indexed‎: PubMed 26341961

DOI‎: 10.1111/ejh.12679

https://www.ncbi.nlm.nih.gov/pubmed/26341961 (새로운 창 열기)

철분정맥주사

Management of anaemia and iron deficiency in patients with cancer: ESMO clinical practice guidelines. (새로운 창 열기)

Aapro M, Beguin Y, Bokemeyer C, Dicato M, Gascón P, Glaspy J, Hofmann A, Link H, Littlewood T, Ludwig H, Österborg A, Pronzato P, Santini V, Schrijvers D, Stauder R, Jordan K, Herrstedt J; ESMO Guidelines Committee

Source‎: Ann Oncol 2018;29(Supplement_4):iv96-110.

Indexed‎: PubMed 29471514

DOI‎: 10.1093/annonc/mdx758

https://www.ncbi.nlm.nih.gov/pubmed/29471514 (새로운 창 열기)

Intravenous iron in oncology. (새로운 창 열기)

Auerbach M, Ballard H.

Source‎: J Natl Compr Canc Netw 2008;6(6):585-92.

Indexed‎: PubMed 18597712

https://www.ncbi.nlm.nih.gov/pubmed/18597712 (새로운 창 열기)

Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia. (새로운 창 열기)

Calleja JL, Delgado S, Del Val A, Hervás A, Larraona JL, Terán Á, Cucala M, Mearin F; Colon Cancer Study Group.

Source‎: Int J Colorectal Dis 2016;31(3):543-51.

Indexed‎: PubMed 26694926

DOI‎: 10.1007/s00384-015-2461-x

https://www.ncbi.nlm.nih.gov/pubmed/26694926 (새로운 창 열기)

How I treat cancer-associated anemia. (새로운 창 열기)

Gilreath JA, Rodgers GM

Source‎: Blood 2020;136(7):801-13.

Indexed‎: PubMed 32556170

DOI‎: 10.1182/blood.2019004017

https://www.ncbi.nlm.nih.gov/pubmed/32556170 (새로운 창 열기)

Total dose iron dextran infusion in cancer patients: is it SaFe2+? (새로운 창 열기)

Gilreath JA, Stenehjem DD, Rodgers GM.

Source‎: J Natl Compr Canc Netw 2012;10(5):669-76.

Indexed‎: PubMed 22570295

https://www.ncbi.nlm.nih.gov/pubmed/22570295 (새로운 창 열기)

Biosimilar erythropoiesis-stimulating agents are an effective and safe option for the management of myelofibrosis-related anemia. (새로운 창 열기)

Inzoli E, Crisà E, Pugliese N, Civettini I, Lanzarone G, Castelli A, Martinelli V, Montelisciani L, Antolini L, Gambacorti-Passerini C, Elli EM

Source‎: Eur J Haematol. 2023 110(4):354-61.

Indexed‎: PubMed 36480004

DOI‎: 10.1111/ejh.13910

https://pubmed.ncbi.nlm.nih.gov/36480004/ (새로운 창 열기)

Intravenous iron therapy to treat anemia in oncology: a mapping review of randomized controlled trials. (새로운 창 열기)

Lim J, Auerbach M, MacLean B, Al-Sharea A, Richards T

Source‎: Curr Oncol. 2023 24;30(9):7836-51.

Indexed‎: PubMed 37754484

DOI‎: 10.3390/curroncol30090569

https://pubmed.ncbi.nlm.nih.gov/37754484/ (새로운 창 열기)

The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents. (새로운 창 열기)

Mhaskar R, Wao H, Miladinovic B, Kumar A, Djulbegovic B.

Source‎: Cochrane Database Syst Rev 2016;(2):CD009624.

Indexed‎: PubMed 26845108

DOI‎: 10.1002/14651858.CD009624.pub2

https://www.ncbi.nlm.nih.gov/pubmed/26845108 (새로운 창 열기)

Perioperative anemia management in colorectal cancer patients: a pragmatic approach. (새로운 창 열기)

Muñoz M, Gómez-Ramírez S, Martín-Montañez E, Auerbach M.

Source‎: World J Gastroenterol 2014;20(8):1972-85.

Indexed‎: PubMed 24587673

DOI‎: 10.3748/wjg.v20.i8.1972

https://www.ncbi.nlm.nih.gov/pubmed/24587673 (새로운 창 열기)

Practical clinical consensus guidelines for the management of cancer associated anemia in low- and middle-income countries. (새로운 창 열기)

Parikh PM, Aggarwal S, Biswas G, Gulia S, Agarwala V, Basade M, Mohapatra PN, Vamshi KM, Warrier A, Prasad K, Roy P, Chandrakant MV, Malhotra H, Hingmire S, Paul D, Maniar V, Gupta A, Panda SS, Samar A, Rohatgi N, Dattatreya S, Krishnamurthy M, Thirumalairaj R

Source‎: South Asian J Cancer. 2023 15;12(2):93-9.

Indexed‎: PubMed 37969669

DOI‎: 10.1055/s-0043-1771445

https://pubmed.ncbi.nlm.nih.gov/37969669/ (새로운 창 열기)

Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha. (새로운 창 열기)

Pedrazzoli P, Farris A, Del Prete S, Del Gaizo F, Ferrari D, Bianchessi C, Colucci G, Desogus A, Gamucci T, Pappalardo A, Fornarini G, Pozzi P, Fabi A, Labianca R, Di Costanzo F, Secondino S, Crucitta E, Apolloni F, Del Santo A, Siena S.

Source‎: J Clin Oncol 2008;26(10):1619-25.

Indexed‎: PubMed 18375891

DOI‎: 10.1200/JCO.2007.12.2051

https://www.ncbi.nlm.nih.gov/pubmed/18375891 (새로운 창 열기)

Addition of iron to erythropoiesis-stimulating agents in cancer patients: a meta-analysis of randomized trials. (새로운 창 열기)

Petrelli F, Borgonovo K, Cabiddu M, Lonati V, Barni S.

Source‎: J Cancer Res Clin Oncol 2012;138(2):179-87.

Indexed‎: PubMed 21972052

DOI‎: 10.1007/s00432-011-1072-3

https://www.ncbi.nlm.nih.gov/pubmed/21972052 (새로운 창 열기)

Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemia. (새로운 창 열기)

Steinmetz T, Tschechne B, Harlin O, Klement B, Franzem M, Wamhoff J, Tesch H, Rohrberg R, Marschner N.

Source‎: Ann Oncol 2013;24(2):475-82.

Indexed‎: PubMed 23071262

DOI‎: 10.1093/annonc/mds338

https://www.ncbi.nlm.nih.gov/pubmed/23071262 (새로운 창 열기)

종양학과
빈혈 관리
한국어
빈혈 관리
https://assetsnffrgf-a.akamaihd.net/assets/ct/5a91b826b0/images/syn_placeholder_sqr.png

병원 교섭 위원회 지역 담당자에게 연락하기

세계적으로 제공되는 무료 서비스. 여호와의 증인을 치료하는 의사라면 하루 중 어느 때이든 이용할 수 있습니다.

연락하기

의학 자료집

다루는 주제들: 수혈 없이 출혈과 빈혈을 관리하기 위한 임상 전략, 의료에 대한 여호와의 증인의 종교적·윤리적 입장, 세계적인 네트워크를 형성하고 있는 병원 교섭 위원회를 통해 증인들이 의료계에 제공하는 서비스.

다운로드하기

동영상

여호와의 증인을 치료하는 임상의를 위한 자료. 선택 가능한 치료법과 의학적·윤리적으로 고려해야 할 사항을 볼 수 있습니다.

동영상 보기